Resveratrol from Peanut Sprout Extract Promotes NK Cell Activation and Antitumor Activity

Hyunmin Chung1,2, Seong Ho Bak1,2, Eunju Shin1,3

  • 1Aging Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 34141, Republic of Korea.

Biomolecules & Therapeutics
|February 19, 2025
PubMed

Insights

Peanut sprout extract cultivated with fermented sawdust medium (PSEFS) significantly boosts natural killer (NK) cell activation more than resveratrol alone. This suggests PSEFS as a promising immune booster for cancer immunotherapy.

Area of Science:

  • Immunology
  • Oncology
  • Natural Products

Background:

  • Natural killer (NK) cells are vital for innate immunity and cancer therapy, but their efficacy against solid tumors is limited.
  • Combination therapies and immune-boosting health supplements are being explored to enhance NK cell activity.
  • Resveratrol, found in plants like peanuts and grapes, shows anticancer effects and immune cell activation properties.

Purpose of the Study:

  • To compare the efficacy of resveratrol and a specific peanut sprout extract (PSEFS) in enhancing NK cell activity.
  • To investigate PSEFS's potential to potentiate NK cell anticancer functions, including survival, tumor cell lysis, and activation.

Main Methods:

  • Comparison of PSEFS and resveratrol effects on NK cell activation.
  • In vivo investigation of PSEFS in mice, assessing NK cell survival, tumor cell lysis, and activation.
  • Analysis of PSEFS composition for resveratrol content and health benefits.

Main Results:

  • PSEFS demonstrated significantly enhanced NK cell activation compared to an equivalent dose of resveratrol.
  • PSEFS was found to potentiate NK cell anticancer activity in mice.
  • The study highlighted the concentrated resveratrol content and maximized benefits of PSEFS.

Conclusions:

  • PSEFS is a more effective NK cell activator than resveratrol alone.
  • PSEFS shows potential as a novel immune booster for cancer immunotherapy, particularly for enhancing NK cell-mediated anticancer effects.